dsip high purity Vial (5mg) | Research Peptide Delta sleep-inducing peptide (DSIP) -

The compounds under review are not FDA-approved and will not become so this summer

No lethal dose has been established in animal studies, even at dosages many orders of magnitude higher than those used in therapeutic research

Most people start BPC-157 at 200 to 500 mcg per day

Key Research Areas Gastrointestinal mucosal protection BPC-157 is studied in gut tissue models for its interaction with gastric mucosal repair pathways, including protection against NSAID-induced lesions and inflammatory bowel disease models Tendon and ligament biology Investigated in in-vitro and rodent models for its influence on fibroblast activity, collagen synthesis, and tendon-to-bone attachment repair Angiogenesis Studied for its promotion of VEGF expression and new blood vessel formation in wound healing and ischaemia models Neuroprotection Referenced in studies examining dopamine and serotonin system modulation

It has also created a cultural moment in which the public conflates "peptide" with "effective" without the scientific scaffolding that makes GLP-1 drugs credible